gene in people relapsing just after procedure with the BCL2 antagonist venetoclax. sixty six Resistance to those brokers has become affiliated with these mutations in all-around 70% of situations, Even though they usually are subclonal and their unique part producing resistance should be tested.??? "???????????????????????????????????????????????")